Flupenthixol decanoate and relapse prevention in alcoholics: Results from a placebo-controlled study

Alcohol and Alcoholism

Volumn 36, Issue 4, 2001, Pages 329-334

  Wiesbeck, Gerhard A ^a   Weijers, Heinz Gerd ^a   Lesch, Otto M ^b   Glaser, Thomas ^c   Toennes, Peter Joachim ^c   Boening, Jobst ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COCAINE; DOPAMINE; FLUPENTIXOL DECANOATE; PLACEBO; SEROTONIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLICS ANONYMOUS; ALCOHOLISM; ARTICLE; BINDING SITE; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NEUROBIOLOGY; OUTPATIENT CARE; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; STATISTICAL ANALYSIS; SUPPORT GROUP;

ANIMALIA;

EID: 0034937648     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/36.4.329     Document Type: Article

References (44)

1. The Withdrawal Syndrome Scale for alcohol and related psychoactive drugs: Interobserver reliability and construct validity
2. Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: A multicenter trial in fenoral practice
3. The role of neurotransmitters in alcohol dependence: Animal research
4. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward
5. Review of neurotransmitters and their role in alcoholism treatment
6. A prospective multicenter study on inpatient treatment for alcoholics: 15- and 48-months follow-up
7. Diagnosis of alcoholism: The Munich Alcoholism Test (MALT)
8. Pharmacological treatment of alcohol dependence - A review of the evidence
9. Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate: A preliminary report
10. Flupentixol-induced aversion to crack cocaine
11. Receptor binding of flupenthixol and other neuroleptics
12. The assessment of anxiety states by rating
13. A rating scale for depression
14. Striatal D-2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
15. Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program
16. The 'Goettinger Abhaengigkeitsskala' (GABS). An instrument for the differential assessment of the severity of alcohol dependence
17. Flupenthixol and desipramine treatment of crack users: Double-blind results
18. Continuous or intermittent cocaine administration: Effects of flupenthixol treatment during withdrawal
19. Review and discussion of statistical analysis of controlled clinical trials in alcoholism
20. Subtypes of alcoholism and their role in therapy
21. The course of alcoholism. Long-term prognosis in different types
22. Flupenthixol treatment of cocaine abusers with schizophrenia: A pilot study
23. Alcohol reinforcement and neuropharmacological therapeutics
24. Antagonism of cocaine's reinforcing and discriminative stimulus effects by α-flupenthixol
25. Animal models of alcoholism: Neurobiology of high alcohol-drinking behavior in rodents
26. Densities of dopamine D-2 receptors are reduced in CNS regions of alcohol-preferring P rats
27. Long-acting injectable bromocriptine does not reduce relapse in alcoholics
28. Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effect of cocaine in rhesus monkeys
29. Alcoholism and the dopaminergic system: A review
30. Allelic association of the D-2 dopamine receptor gene with receptor binding characteristics in alcoholism
31. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes
32. A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats
33. The neural basis of drug craving: An incentive-sensitization theory of addiction
34. Neuroleptics in the treatment of drug dependence in schizophrenics
35. Pharmacological effects of lisuride shorten expectations to receive the drug and prolong the latency of relapse in cleaned alcoholics
36. The AA and ANA rat lines selected for differences in voluntary alcohol consumption
37. Flupentixol in der Therapie bei Suchterkrankungen
38. Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism
39. The development of a questionnaire to measure severity of alcohol dependence
40. Drug therapy for alcohol dependence
41. Personality disorder and social functioning
42. From controlled intake to loss of control: The irreversible development of drug addiction in the rat